Thromb Haemost
DOI: 10.1055/a-2530-7553
Coagulation and Fibrinolysis

Utility of Sepsis-induced Coagulopathy among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study

1   Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan
2   Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan
,
1   Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan
,
Kazuma Yamakawa
3   Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
,
Toshikazu Abe
4   Department of Emergency and Critical Care Medicine, Tsukuba Memorial Hospital, Tsukuba, Japan
5   Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan
6   Department of Health Services Research, Faculty of Medicine, University of Tsukuba, Japan
,
Seitaro Fujishima
7   Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan
,
Shigeki Kushimoto
8   Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
,
Toshihiko Mayumi
9   Department of Intensive Care Unit, Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Japan
,
Hiroshi Ogura
10   Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan
,
Daizoh Saitoh
11   Graduate School of Emergency Medical System, Kokushikan University, Tokyo, Japan
,
Atsushi Shiraishi
12   Emergency and Trauma Center, Kameda Medical Center, Kamogawa, Japan
,
Yutaka Umemura
13   Devision of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan
,
Yasuhiro Otomo
14   National Hospital Organization (NHO) Disaster Medical Center, Tokyo, Japan
,
on behalf of the Japanese Association for Acute Medicine (JAAM)› Author Affiliations

Funding This study was supported by JSPS KAKENHI Grant no. 23K08455 and a Japan Blood Products Organization 2024 scholarship.


Abstract

Background

The criteria for diagnosing sepsis-induced coagulopathy (SIC) may overlap with those of Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC). This study determined if the diagnostic criteria of SIC overlap with JAAM DIC diagnostic criteria for identifying patients with DIC according to the International Society on Thrombosis and Haemostasis (ISTH) criteria and whether the patients diagnosed with these criteria have the same prognosis.

Methods

This multicenter retrospective study included patients with sepsis diagnosed using the JAAM and ISTH DIC and SIC criteria on days 1 and 4. The established ISTH DIC criteria was the reference standard for primary outcome that compared the characteristics of SIC and JAAM DIC. Secondary outcomes were multiple organ dysfunction syndrome (MODS), ventilator-free and intensive care unit–free days, and in-hospital mortality.

Results

A total of 1,438 patients were included in this study. On day 1, the JAAM DIC and SIC criteria diagnosed almost all patients with ISTH DIC (98 and 94%, respectively), predicting ISTH DIC (area under the receiver operating curve [AUC]: 0.740 versus 0.752, p = 0.523) and MODS (AUC: 0.686 versus 0.697, p = 0.546) on day 4 and progressing to ISTH DIC in the same proportion (28.6 versus 30.1%, p = 0.622). There were no differences in survival probabilities (p = 0.196) or secondary outcomes between patients diagnosed using JAAM DIC and SIC criteria on day 1.

Conclusion

SIC and JAAM DIC diagnoses were equal among patients with sepsis, suggesting that SIC criteria add little to current DIC scoring systems.

Data Availability Statement

Datasets supporting the conclusions of this article will be provided upon reasonable request to the corresponding author.


Authors' Contribution

S.G., T.W., K.Y., T.A., S.F., S.K., T.M., H.O., D.S., A.S., Y.U., and Y.O. planned the study, determined the methods, developed a web-based registration system, and collected, analyzed, and interpreted the data. T.A., D.S., A.S., and Y.U. constructed the dataset and fixed it for analysis. S.G. and W.A. drafted the manuscript. Y.O. supervised all study processes and approved the study. All the authors discussed the results, critically revised the manuscript, edited the figures and tables, and approved the final version.


Supplementary Material



Publication History

Received: 16 October 2024

Accepted: 31 January 2025

Accepted Manuscript online:
03 February 2025

Article published online:
27 February 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86 (05) 1327-1330
  • 2 Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32 (12) 2416-2421
  • 3 Gando S, Iba T, Eguchi Y. et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006; 34 (03) 625-631
  • 4 Gando S, Saitoh D, Ogura H. et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 2008; 36 (01) 145-150
  • 5 Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 1983; (49) 265-275
  • 6 Gando S. The utility of a diagnostic scoring system for disseminated intravascular coagulation. Crit Care Clin 2012; 28 (03) 373-388, vi vi.
  • 7 Takemitsu T, Wada H, Hatada T. et al. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost 2011; 105 (01) 40-44
  • 8 Yoshimura J, Yamakawa K, Ogura H. et al. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Crit Care 2015; 19 (01) 78
  • 9 Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 2016; 14 (03) 518-530
  • 10 Squizzato A, Gallo A, Levi M. et al. Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis. J Thromb Haemost 2020; 18 (09) 2400-2407
  • 11 Gando S, Saitoh D, Ogura H. et al; Japanese Association for Acute Medicine Sepsis Registry Study Group. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 2013; 17 (03) R111
  • 12 Gando S, Shiraishi A, Yamakawa K. et al; Japanese Association for Acute Medicine (JAAM) Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) Study Group. Role of disseminated intravascular coagulation in severe sepsis. Thromb Res 2019; 178: 182-188
  • 13 Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open 2017; 7 (09) e017046
  • 14 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
  • 15 Iba T, Levy JH, Yamakawa K, Thachil J, Warkentin TE, Levi M. Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J Thromb Haemost 2019; 17 (08) 1265-1268
  • 16 Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 2019; 17 (11) 1989-1994
  • 17 Iba T, Levi M, Thachil J, Helms J, Scarlatescu E, Levy JH. Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. J Thromb Haemost 2023; 21 (01) 145-153
  • 18 Iba T, Arakawa M, Levy JH. et al. Sepsis-induced coagulopathy and Japanese Association for Acute Medicine DIC in coagulopathic patients with decreased antithrombin and treated by antithrombin. Clin Appl Thromb Hemost 2018; 24 (07) 1020-1026
  • 19 Abe T, Ogura H, Shiraishi A. et al; JAAM FORECAST group. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit Care 2018; 22 (01) 322
  • 20 Abe T, Yamakawa K, Ogura H. et al; JAAM SPICE Study Group. Epidemiology of sepsis and septic shock in intensive care units between sepsis-2 and sepsis-3 populations: sepsis prognostication in intensive care unit and emergency room (SPICE-ICU). J Intensive Care 2020; 8: 44
  • 21 Umemura Y, Abe T, Ogura H. et al. Hour-1 bundle adherence was associated with reduction of in-hospital mortality among patients with sepsis in Japan. PLoS One 2022; 17 (02) e0263936
  • 22 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20 (06) 864-874
  • 23 Levy MM, Fink MP, Marshall JC. et al; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31 (04) 1250-1256
  • 24 Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286 (14) 1754-1758
  • 25 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
  • 26 Iba T, Arakawa M, Di Nisio M. et al. Newly proposed sepsis-induced coagulopathy precedes International Society on Thrombosis and Haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med 2020; 35 (07) 643-649
  • 27 Yamakawa K, Yoshimura J, Ito T, Hayakawa M, Hamasaki T, Fujimi S. External validation of the two newly proposed criteria for assessing coagulopathy in sepsis. Thromb Haemost 2019; 119 (02) 203-212
  • 28 Helms J, Severac F, Merdji H. et al; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). Performances of disseminated intravascular coagulation scoring systems in septic shock patients. Ann Intensive Care 2020; 10 (01) 92
  • 29 Wang B, Zhang B, Shen Y, Li J, Yuan X, Tang N. Validation of two revised, simplified criteria for assessing sepsis-associated disseminated intravascular coagulation in ICU patients with sepsis-3: a retrospective study. Lab Med 2023; 54 (03) 291-298